LIVN
LivaNova Plc
NASDAQ · Healthcare · Medical - Devices · GB
$78.01
+0.28%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$77.34
From 52W high−8.58%
Volume1.38M
Market cap$4.30B
P/E (TTM)22.6x
P/S (TTM)2.9x
Div yield—
Key dataSep 18, 2026
Open
$77.34
From 52W high
−8.58%
Volume
1.38M
Market cap
$4.30B
ValuationView details →
P/E (Fwd)
17.6x
EV/EBITDA
22.9x
P/E (TTM)
22.6x
RSI (14)
43.5
MomentumView details →
1D Return
+0.28%
YTD Return
+26.45%
SummaryUpdated Jun 1, 2026
LivaNova PLC (NASDAQ:LIVN) is a medical device company founded in 1987 and headquartered in London, United Kingdom. The company was created through the 2015 merger of Cyberonics and Sorin Group, combining expertise in neuromodulation and cardiac surgery technologies. LivaNova designs, develops, manufactures, and sells therapeutic solutions globally, focusing on three core segments: cardiopulmonary products for heart surgery, neuromodulation devices for neurological conditions, and advanced circulatory support systems. The company serves hospitals, medical institutions, and healthcare providers worldwide through direct sales representatives and independent distributors.
Similar companies
Latest newsMore news →
LivaNova PLC reported its second-quarter 2026 financial results, with revenue of $390.6 million, up 10.8% on a reported basis and 9.8% on a constant-currency basis year-over-year, and U.S. GAAP diluted EPS of $1.93.46d agoJette Nygaard-Andersen was elected to the Board of Directors of LivaNova PLC after its Annual General Meeting on June 10.101d ago